Rd Biosciences Inc San Diego, CA - 92121

Rd Biosciences Inc is categorized under Commercial Biotechnical Research in San Diego, CA and active since 2007.

Rd Biosciences Inc was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.

If you are seeking more information, feel free to contact Xifu Liu at the company’s single location by writing to 6048 Cornerstone Court West B1, San Diego, California CA 92121 or by phoning (858) 633-8093. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Rd Biosciences Inc
Contact Person: Xifu Liu
Address: 6048 Cornerstone Court West B1, San Diego, California 92121
Phone Number: (858) 633-8093
Website Address: rdbiosciences.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Biotechnical Research
SIC Code: 8731
NAICS Code: 541711
Share This Business:

Rd Biosciences Inc was started in 2007 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Xifu Liu for inquiries that concern Rd Biosciences Inc by calling the company number (858) 633-8093, as your correspondence is most welcome. Additionally, the physical location of the single location of Rd Biosciences Inc can be found at the coordinates 32.897086,-117.189671 as well as the street address 6048 Cornerstone Court West B1 in San Diego, California 92121.

For its online presence, you may visit Rd Biosciences Inc’s website at rdbiosciences.com and engage with its social media outlets through on Twitter and on Facebook.